Studie
A critical evaluation of NAD+ precursor claims and the sirtuin narrative advanced in David Sinclair's Lifespan
PRIMÄR
Tier 2
2022
StudiedesignPRIMÄR
TierTier 2, Strong human evidence, hard endpoints or biomarkers
År2022
TidskriftNutrients (PMC)
N4
Tillagd i NO1GEVITYmaj 20, 2026
Citerad av
2 encyklopediartiklar refererar till denna studie.